SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-585576
Filing Date
2016-05-10
Accepted
2016-05-10 16:07:25
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d145010d10q.htm 10-Q 614945
2 EX-31.1 d145010dex311.htm EX-31.1 8215
3 EX-31.2 d145010dex312.htm EX-31.2 8201
4 EX-32.1 d145010dex321.htm EX-32.1 4242
11 GRAPHIC g145010g19f16.jpg GRAPHIC 165393
  Complete submission text file 0001193125-16-585576.txt   3400194

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT enta-20160331.xml EX-101.INS 529436
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20160331.xsd EX-101.SCH 32889
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20160331_cal.xml EX-101.CAL 62081
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20160331_def.xml EX-101.DEF 133133
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20160331_lab.xml EX-101.LAB 307637
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20160331_pre.xml EX-101.PRE 226400
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 161635802
SIC: 2834 Pharmaceutical Preparations